re: NOVN... It is down on the same news as Wyeth, really not too hard to find-
Wyeth- "...government researchers halted a study of the drugmaker's Prempro hormone replacement treatment on concern it may raise patients' risk of breast cancer and heart disease."
"Shares of other makers of hormone therapies, including Noven Pharmaceuticals Inc. and Novavax Inc., also fell..."
"Shares of Noven, which makes patches that deliver hormones through the skin, fell $5.60, or 27 percent, to $14.99. Noven is the only company that makes a patch, called CombiPatch, that combines estrogen and progestin..."